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1.  Introduction
Although injured axons in the peripheral nervous 
system (PNS) can regenerate and lead to functional 
recovery by innervating the original target, the ex-
tent of regeneration varies depending on the type of 
nerves and injuries [1,2]. For instance, a complete 
axotomy of peripheral nerve results in wrong target-
ing of regenerating axons between cutaneous sen-
sory and motor organs [3]. Numerous studies have 
identified intrinsic and extrinsic molecular factors 
involved in regeneration processes of the injured 
peripheral nerves [3,4]. Some of the prototypical 
examples of intrinsic factors include axonal growth-
associated protein with an apparent molecular 
weight of 43 kDa (GAP-43) and trophic factors such 
as nerve growth factor (NGF), brain-derived neuro-
trophic factor (BDNF), glial cell line-derived neu-
rotrophic factor (GDNF), ciliary neurotrophic factor 
(CNTF), and neurotrophic factor 3 and 4 (NT-3 and 
-4) [5−8]. GAP-43 is highly induced at the gene ex-
pression level in the injured nerve and is thus rec-
ognized as a regeneration marker protein rather 
than a regeneration trigger [9,10]. Besides intrinsic 
influences, regenerating peripheral axons are greatly 
affected by non-neuronal environments. Schwann 
cells are activated around the injury area and are 
most likely the most important non-neuronal influ-
ence on injured nerves. It has been well demon-
strated that injured axons at the distal portion 
undergo Wallerian degeneration in which the debris 
from degenerating tissues is cleared by phagocytic 
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activity of Schwann cells and macrophages that 
have infiltrated from blood vessels [1]. Schwann 
cells are also known to migrate along the injury area 
and guide regrowing axons [12,13]. Finally, they are 
involved in remyelination of newly formed axons. 
Thus, physical and chemical interactions between 
Schwann cells and injured axons are critical for 
successful regrowth.
Recent studies have begun to provide evidence 
that natural herbal drugs such as ginsenoside Rb 
and Hominis placenta (Jahageo) may facilitate ax-
onal regeneration after peripheral nerve injury 
[14,15]. Considering that herbal drugs contain di-
verse chemical ingredients that might be involved 
in the responsiveness of injured nerves, potential 
effects of herbal drugs on axonal regeneration could 
be highly feasible.
Here, we investigated whether Sanyak (SY; 
Dioscoreae rhizoma) has any growth-promoting ac-
tivity on sciatic nerve axons after injury in the rat. 
In oriental medicinal therapy, SY has been prescribed 
for diverse physiological abnormalities including 
muscle pain, renal, digestive and hepatic problems. 
A recent study indicated its inhibitory activity on 
proinflammatory cytokines, and antioxidant activity, 
for the protection of DNA [16−18]. Our study dem-
onstrates that SY administration into injured periph-
eral nerve induces activation of several molecular 
components that are involved in axonal regenera-
tion, and thus promote nerve regrowth.
2.  Materials and Methods
2.1.  Experimental animals
Sprague-Dawley rats (8 weeks old) were used in this 
experiment. They were placed in an animal room 
with regulated temperature (22ºC), 60% of humid-
ity, and a 12 hour light and 12 hour dark cycle. They 
were allowed to eat commercial rat chow (Samyang 
Co., Korea) and drink water ad libitum. Rat care 
and all experimental procedures were in accordance 
with the Animal Use Statement and Ethics Committee 
Approval Statement for Animal Experiments at 
Daejeon University (Daejeon, Korea).
2.2.  Drugs
SY was obtained from Daejeon University Oriental 
Medicine Hospital (Daejeon, Korea). SY (58 g dry 
weight) was resuspended in 2 liters of water, heat-
extracted with 2 liters of water for 3 hours, and 
filtered three times. The filtered fluid was distilled 
using the rotary vacuum evaporator (Büchi 461, 
Eyela, USA). Concentrated solutions were frozen at 
−70ºC for 4 hours, and freeze-dried for 24 hours. 
The yield for SY was 3.2 g from 58 g of the initial 
raw materials. The product was kept at 4ºC, and 
dissolved in water. The stock solution (10 mg/mL in 
phosphate buffered saline) was stored at −20ºC and 
used for experiments by diluting with physiological 
saline solution (0.9% NaCl in water) before use. SY 
(5 μL of 10 mg/mL) or an equivalent volume of saline 
(0.9% NaCl) was directly applied into the crush sites.
2.3.  Surgery and tissue preparation
Rats were anesthetized with a mixture of ketamine 
(80 mg/kg) and xylazine (5 mg/kg). Sciatic nerve 
was exposed and crushed with a pair of forceps 
held tightly for 30 seconds twice at 1 minute inter-
vals. Animals were allowed to recover from an-
esthesia and were sacrificed 5 days later. Animals 
were deeply anesthetized again with a mixture of 
ketamine and xylazine, and the proximal and distal 
portions of the injury site of the sciatic nerves were 
dissected separately, immediately frozen, and kept 
at −70ºC until their use for immunohistochemistry 
or Western blot analysis.
2.4.  Immunohistochemistry
For immunohistochemistry experiments, dissected 
nerve tissue was immediately frozen at −75ºC and 
embedded into OCT medium. Sciatic nerve sections 
(20 μm) were cut using a cryostat and mounted on 
positively charged slides. Sections on a slide were 
fixed with 4% paraformaldehyde, 4% sucrose in 
phosphate-buffered saline (PBS) at room tempera-
ture for 40 minutes, permeabilized with 0.5% noni-
det P-40 in PBS, and blocked with 2.5% horse serum 
and 2.5% bovine serum albumin for 4 hours at room 
temperature. Sections were incubated with primary 
antibody, and then incubated with fluorescein-goat 
anti-mouse (Molecular Probes, Eugene, OR, USA) or 
rhodamine-goat anti-rabbit secondary antibodies 
(Molecular Probes, USA) in 2.5% horse serum and 
2.5% bovine serum albumin for 1 hour at room tem-
perature. Slides were subsequently cover-slipped 
with gelatin mount medium. The primary antibody 
reaction was performed with single or double anti-
bodies, depending on experimental purposes, and 
were followed with corresponding specific second-
ary antibody reactions. The primary antibodies used 
were anti-NF-200 antibody (Sigma, St. Louis, MO, 
USA), anti-Cdc2 antibody (Santa Cruz Biotech, Santa 
Cruz, CA, USA), anti-phospho-vimentin antibody 
(MBL, USA,) and anti-GAP-43 antibody (Santa Cruz 
Biotech, Santa Cruz, CA, USA). In some studies, 
Hoechst staining for nuclear visualization was also 
performed following the first washing step after 
the secondary antibody reaction. Tissue sections 
were treated with 25 μg/mL of Hoechst 33258 dye 
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(Sigma, St. Louis, MO, USA) in 0.1% Triton X-100 in 
PBS for 10 minutes. Sections were observed with a 
Nikon fluorescence microscope (E-600, Nikon, Japan) 
and the images were captured using a Nikon camera 
(DXM 1200F, Nikon, Japan). The merged images were 
produced by using layer blending mode options on 
Adobe Photoshop (version 5.5).
2.5.  Western blot analysis
Nerve tissue was washed with ice-cold PBS, and son-
icated in 50−200 μL of Triton lysis buffer (20 mM Tris, 
pH 7.4, 137 mM NaCl, 25 mM β-glycerophosphate, 
pH 7.14, 2 mM sodium pyrophosphate, 2 mM EDTA, 
1 mM Na3VO4, 1% Triton X-100, 10% glycerol, 5 μg/
mL leupeptin, 5 μg/mL aprotinin, 3 μM benzami-
dine, 0.5 mM DTT, 1 mM PMSF). Protein (15 μg) was 
resolved in 12% SDS polyacrylamide gel and trans-
ferred to Immobilon polyvinylidenedifluoride mem-
branes (Millipore, Billerica, MA, USA). Blots were 
blocked with 5% nonfat dry milk in PBST (17 mM 
KH2PO4, 50 mM Na2HPO4, 1.5 mM NaCl, pH 7.4, and 
0.05% Tween-20) for 1 hour at room temperature 
and incubated overnight at 4ºC in 0.1% Triton X-100 
in PBS plus 5% nonfat dry milk containing antibodies. 
Protein bands were detected using the Amersham 
ECL kit (Amersham Pharmacia Biotech, USA), with 
horseradish peroxidase-conjugated secondary goat 
anti-rabbit or goat anti-mouse antibodies (Trans-
duction Laboratories, Lexington, KY, USA). The pri-
mary antibodies used in the present study were an 
anti-GAP-43 antibody (Santa Cruz Biotech, Santa 
Cruz, CA, USA), an anti-Cdc2 antibody (Santa Cruz 
Biotech, Santa Cruz, CA, USA) and an anti-actin 
antibody (Santa Cruz Biotech, Santa Cruz, CA, USA).
2.6.  Retrograde tracing
The sciatic nerve of rats anesthetized with ketamine 
and xylazine was exposed and fluorescent lipophilic 
carbocyanine dye l,l-dioctodecyl-3,3,3,3tetra-
methylindocarbocyanine perchlorate (DiI, Molecular 
Probe; 5 μL of 3% in DMSO) was applied 0.5 cm distal 
to the injury site with a microsyringe. The incision 
was sutured, and the animals were returned to 
their cages after they recovered from narcosis. DiI-
labeled sensory neurons in the dorsal root ganglion 
(DRG) were visualized and measured under fluo-
rescence microscope by an observer unaware of the 
experimental treatment.
2.7.  Statistical analysis
Comparisons among experimental groups were 
made by two sample Student’s t-test. A criterion 
of p values less than 0.05 was applied to assess 
statistical significance.
3.  Results
3.1.  Changes in levels of GAP-43 
production
In order to study possible effects of SY on facilitated 
axonal regeneration, protein lysates prepared from 
proximal and distal portions of the injured sciatic 
nerves were analyzed by Western and immunofluo-
rescence staining. GAP-43 was not detected in the 
intact sciatic nerve, but largely induced after injury 
(Figure 1A). SY treatment further elevated GAP-43 
levels in the injured nerve. The intensity of the 
GAP-43 protein band was higher in the distal sciatic 
nerve than proximal nerve in both saline and SY-
treated groups. To investigate the distribution of 
induced GAP-43 protein in the injured nerve tis-
sue, immunofluorescence staining was performed 
(Figure 1B). In the saline-treated group, moderate 
levels of GAP-43 protein signal was detected through-
out the nerve with a pattern of gradual decrease to-
ward the distal end. In the SY-treated group, levels 
of GAP-43 signal were consistent throughout the dis-
tal portion of the nerve, thus revealing higher signals 
in the 5 mm distal area compared with saline control. 
This demonstrates elevated GAP-43 protein levels 
in the SY group compared with the saline control, 
as was also demonstrated by Western blot analysis.
3.2.  Histological analysis of regenerative 
responses
To determine whether SY treatment affects axonal 
regeneration, growing axons in the distal portion of 
the nerve were analyzed by immunofluorescence 
staining. Five days after nerve injury in the saline-
treated group, axonal staining with NF-200 protein 
was clearly observed at the injury site, but was 
greatly reduced at 3 mm and 5 mm portions distal 
to the injury site (Figure 2). In contrast, SY treat-
ment showed consistent axonal staining at the 3 mm 
and 5 mm distal areas.
To further investigate changes in axonal regen-
eration following SY treatment, neuronal cell bodies 
corresponding to sciatic nerve axons were analyzed 
from the DRG at lumbar 4 and 5 and the spinal cord 
between the lower thoracic and upper lumbar levels 
by retrograde tracing. As shown in Figure 3A, DiI-
labeled neuronal cell bodies were clearly observed 
in DRG sections. In the saline-treated group, mostly 
round shape labeled cells together with a few weakly 
stained small cells, were seen in the tissue. The 
number of DiI-labeled cells was significantly higher 
in the SY-treated group than saline control (Figure 
3C). Moreover, the processes around the cell bodies 
were observed more frequently in the SY-treated 
group. Regeneration responses of the motor neuron 
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Figure 1 Analysis of GAP-43 protein levels in the injured sciatic nerve. (A) Western blot analysis of GAP-43 protein. 
The sciatic nerve lysate at the injury area (1 cm length) was prepared 5 days after injury, and the lysate from the sci-
atic nerve from intact animal was used as a negative control. 15 μg of protein was used for individual samples, and 
Western analysis with anti-actin antibody was used as an internal loading control. (B) Comparison of GAP-43 protein 
levels between saline- and SY-treated animals in the sciatic nerves by immunofluorescence staining. GAP-43 protein 
signal (in red) was analyzed in longitudinal nerve sections 5 days after injury. GAP-43 protein signal was compared at 
the same distances from the injury site between saline and SY-treated groups.
axons in the injured sciatic nerve were similarly in-
vestigated by measuring DiI-labeled motor neurons 
in the spinal cord ventral horn. As shown in Figure 
3B, DiI-labeled motor neurons were clearly seen in 
the spinal cord sections. The number of labeled cells 
was significantly higher in the SY-treated group 
than saline control (Figure 3C).
3.3.  Changes in Cdc2 activity and cell 
proliferation in regenerating nerves
The cell cycle protein, Cdc2, was investigated in 
the injured sciatic nerves. Cdc2 protein was not 
detected in the intact nerve but was highly induced 
in the distal sciatic nerve after injury (Figure 4A). 
SY treatment further increased Cdc2 in the distal 
nerve. To examine Cdc2 phosphorylation of its sub-
strate protein, vimentin, immunofluorescence stain-
ing was performed in distal sciatic nerve sections. 
Low Cdc2 and phospho-vimentin protein signals 
were detected at the injury site and the signals 
were slightly elevated in the 3 mm and 5 mm distal 
portions of the nerve (Figure 4B). SY treatment in-
creased both Cdc2 and phospho-vimentin signals 
at the 3 mm and 5 mm distal portion of the nerve. 
Merged images of Cdc2 and phospho-vimentin showed 
high colocalization of protein signals in the nerve 
tissue (Figure 4C).
To compare the cell number between different 
treatments, Hoechst nuclear staining of the sciatic 
nerve was performed. After nerve injury, the number 
of nuclei increased to a large extent, particularly at 
the injury site and the adjacent distal area (Figure 
5A). When the number of nuclei were compared be-
tween saline and SY-treated groups at the same 
distances from the injury site, nucleus counts were 
similar at the proximal nerve area between the two 
groups, but were significantly increased at the injury 
site and at the 3 mm distal nerve area in SY-treated 
groups compared with the saline control (Figure 5B).
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Figure 2 Identification of regenerating axons in the sciatic nerve 5 days after injury. Immunofluorescence images of 
NF-200-stained axons in the longitudinal sciatic nerve sections were examined at the injury site, and the areas 3 mm 
proximal, and 3 mm and 5 mm distal to the injury site.
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Figure 3 Retrograde analysis of DiI-labeled neurons after 
sciatic nerve injury. (A) Retrograde tracing of DRG sensory 
neurons 5 days after sciatic nerve injury. DRG at lumbar 4 
and 5 was prepared 5 days after surgical procedure and 
20 μm sections were prepared for further analysis. DiI-
impregnated sensory neurons were visualized under the 
fluorescence microscope (red). The images on the right side 
are the enlarged view of the corresponding images to the 
left side. (B) Retrograde tracing of motor neuron cell bodies 
at the ventral horn of the spinal cord 5 days after sciatic 
nerve injury. The longitudinal spinal cord sections were pre-
pared 5 days after surgical procedure and analyzed under 
the fluorescence microscope (red). The images on the right 
side are the enlarged view of the images corresponding to 
the left side. (C) Quantitation of DiI-labeled DRG sensory 
neurons and motor neurons in the spinal cord. The number 
of labeled cells was compared between saline- and SY-
treated cells. Mean ± SEM (n = 4, *p = 0.042, **p = 0.0087).
Growth-promoting activity of Sanyak 233
4.  Discussion
According to the principles of oriental medicine, 
SY is believed to strengthen Qi in the spleen, lung 
and kidneys, and is thus used for treatment of di-
verse symptoms in related organs [16,17]. Here, 
we found that SY treatment improved axonal re-
generation responses toward the distal end of the 
sciatic nerve and upregulated production of several 
key proteins associated with axonal regeneration.
Biochemical and histological analyses strongly 
indicate that SY may facilitate axonal regeneration. 
First, SY treatment increased GAP-43 protein levels 
in the distal portion of the sciatic nerve. GAP-43 is 
strongly induced at the gene expression level in 
neurons after axonal injury, and transported into 
the growth cone which is involved in the process of 
regrowth [9,10]. Thus, our data on higher levels of 
GAP-43 at the distal nerve stump compared with 
the proximal area support the observation that SY 
treatment may be positively associated with the 
growth process connected with GAP-43 activity in 
the distal nerve. Second, our data showed that SY 
treatment increased staining for NF-200 in axons. 
Furthermore, quantitative analysis of axonal re-
generation by counting DiI-labeled neurons whose 
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Figure 4 Cdc2 and phospho-vimentin protein analysis in the sciatic nerve. (A) Western blot analysis of Cdc2 in the 
injured sciatic nerve. Proximal and distal sciatic nerve stumps (0.5 cm length) were prepared from the intact animal, 
saline (Sal), and SY-treated animals. 15 μg of protein lysates was analyzed for Western blot analysis with anti-Cdc2 
and anti-actin antibodies. Western analysis for actin protein was performed as an internal loading control. (B) The 
longitudinal sciatic nerve sections were prepared 5 days after injury from saline (Sal) and SY-treated animals, and 
used for double immunofluorescence staining with anti-Cdc2 (red) and anti-phospho-vimentin antibodies (green). The 
stained nerve sections among different groups were compared at the injury site, and 3 mm and 5 mm distal to the injury 
site. (C) Representative immunofluorescence images, prepared from SY-treated animals, for phospho-vimentin and 
Cdc2 in nerve sections 5 mm distal to the injury site.
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axons underwent axonal regeneration revealed that 
SY increased axonal regeneration. Careful obser-
vation of DiI-labeled sensory neurons in the DRG or 
motor neurons in the spinal cord revealed more in-
tense DiI-labeling intensity in the SY-treated group 
than saline control. This might suggest that indi-
vidual regrowing axons at the distal area were re-
paired more efficiently by SY treatment, rendering 
enhanced labeling of individual neurons with DiI.
The present data showed that SY treatment up-
regulated production of Cdc2 protein levels in the 
injured sciatic nerve. Cdc2 is the prototypical cell 
cycle protein and plays a critical role in the transi-
tion between growth phase 2 to the mitotic phase 
[19]. Previous studies have shown that Cdc2 protein 
and its kinase activity were not found in the intact 
nerve tissues, but strongly induced in Schwann cells 
after nerve injury [20]. The current study showed 
the same pattern of Cdc2 in the injured nerve. Bio-
chemical studies have identified numerous proteins 
as Cdc2 kinase substrates, and most of them are pri-
marily involved in the progression of mitosis [21]. The 
vimentin protein is one of the targets for Cdc2 ki-
nase and was, therefore, investigated in this study. 
Vimentin is an intermediate protein which is involved 
in maintaining the mechanical stability of cells 
[22,23]. Vimentin can be phosphorylated by several 
kinases [24], but its phosphorylation by Cdc2 at Serine 
55 has been suggested to play an important role in 
subsequent phosphorylation of vimentin at another 
site leading to mitotic separation of dividing cells 
[23,25−27]. Furthermore, the phosphorylated form 
of vimentin, created by Cdc2, was found in glial cells 
undergoing migration activity [28]. Thus, it is conceiv-
able that Cdc2 phosphorylation of vimentin may 
function for mitosis and cell migratory activity, as 
has been demonstrated by Cdc2 phosphorylation 
of caldesmon in Schwann cells and kidney cell lines 
[20,29]. The present data showed that SY treat-
ment elevated levels of phospho-vimentin in the 
distal area of injured sciatic nerve. Since the acti-
vation of the Cdc2-phospho-vimentin pathway may 
be functionally involved in Schwann cell prolifera-
tion and migration leading to facilitated axonal re-
growth, growth-promoting activity by SY treatment 
could be mediated through Schwann cell activa-
tion. Indeed, our measurement of individual non-
neuronal cells in the sciatic nerve by Hoechst nuclear 
staining showed increased cell counts following 
SY treatments in the distal nerve area, implicating 
possible involvement of the Cdc2-vimentin pathway 
in Schwann cells. In conclusion, SY appears to acti-
vate several molecules known to be important for 
axonal regeneration in the injured peripheral nerve, 
and thus play an important role in facilitated axonal 
regeneration. Further studies to identify key molec-
ular components in SY may be potentially critical 
for the development of therapeutic targets.
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